These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3928760)

  • 1. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
    Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S
    J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
    Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
    J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
    Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
    Matsui M; Temponi M; Ferrone S
    J Immunol; 1987 Sep; 139(6):2088-95. PubMed ID: 3114385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the interaction between a human high molecular weight melanoma-associated antigen and the monoclonal antibodies to three distinct antigenic determinants.
    Giacomini P; Natali P; Ferrone S
    J Immunol; 1985 Jul; 135(1):696-702. PubMed ID: 2582052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis with monoclonal antibodies of the molecular and cellular heterogeneity of human high molecular weight melanoma associated antigen.
    Ziai MR; Imberti L; Nicotra MR; Badaracco G; Segatto O; Natali PG; Ferrone S
    Cancer Res; 1987 May; 47(9):2474-80. PubMed ID: 3552215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfer and co-amplification of a gene encoding a 96-kDa immune IFN-inducible human melanoma-associated antigen. Preferential expression by mouse melanoma host cells.
    Graf LH; Rosenberg CD; Mancino V; Ferrone S
    J Immunol; 1988 Aug; 141(3):1054-60. PubMed ID: 3135310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human anti-high molecular weight-melanoma-associated antigen single-chain Fv fragments isolated from a phage display antibody library.
    Desai SA; Wang X; Noronha EJ; Kageshita T; Ferrone S
    Cancer Res; 1998 Jun; 58(11):2417-25. PubMed ID: 9622083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased surface expression and shedding of tumor associated antigens by human breast carcinoma cells treated with recombinant human interferons or phorbol ester tumor promoters.
    Leon JA; Mesa-Tejada R; Gutierrez MC; Estabrook A; Greiner JW; Schlom J; Fisher PB
    Anticancer Res; 1989; 9(6):1639-47. PubMed ID: 2516715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of melanoma associated antigens in acral lentiginous melanoma and in nodular melanoma lesions.
    Kageshita T; Nakamura T; Yamada M; Kuriya N; Arao T; Ferrone S
    Cancer Res; 1991 Mar; 51(6):1726-32. PubMed ID: 1671829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of human melanoma-associated antigens defined by murine monoclonal antibodies in allogeneic and xenogeneic hosts.
    Hamby CV; Liao SK; Kanamaru T; Ferrone S
    Cancer Res; 1987 Oct; 47(20):5284-9. PubMed ID: 3115563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic in vitro and in vivo anti-tumor effect of daunomycin-anti-96-kDa melanoma-associated antigen monoclonal antibody CL 207 conjugate and recombinant IFN-gamma.
    Matsui M; Nakanishi T; Noguchi T; Ferrone S
    J Immunol; 1988 Aug; 141(4):1410-7. PubMed ID: 3135332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fine specificity of high molecular weight-melanoma-associated antigen-specific cytotoxic T lymphocytes elicited by anti-idiotypic monoclonal antibodies in patients with melanoma.
    Murray JL; Gillogly M; Kawano K; Efferson CL; Lee JE; Ross M; Wang X; Ferrone S; Ioannides CG
    Cancer Res; 2004 Aug; 64(15):5481-8. PubMed ID: 15289358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.